InflaRx Closes $150 Million Underwritten Public Offering, Confirming Significant Dilution

summarizeSummary

InflaRx N.V. announced the closing of its previously disclosed $150 million underwritten public offering, selling 75 million ordinary shares at $2.00 per share, which significantly dilutes existing shareholders.

check_boxKey Events

• Offering Closed

  InflaRx N.V. completed its underwritten public offering on May 7, 2026.

• Proceeds and Shares

  The company raised approximately $150 million by selling 75 million ordinary shares.

• Pricing at Discount

  Shares were sold at $2.00 each, a notable discount to the current market price of $2.6602.

• Significant Dilution

  The offering represents a substantial increase in outstanding shares, leading to significant dilution for current shareholders.

auto_awesomeAnalysis

This 6-K confirms the completion of the substantial capital raise that was initiated with the 424B5 filing yesterday. The offering of 75 million shares for $150 million represents a significant dilution for existing shareholders, especially given the offering price of $2.00 per share was at a notable discount to the current market price of $2.6602. While the capital infusion provides liquidity into 2027, as mentioned in recent Q1 results, the terms of the offering indicate a high cost of capital and will likely exert downward pressure on the stock. Investors should monitor the company's use of these proceeds and future capital needs.